Evolutionary Aspects of Polydistrict Atherosclerosis
NCT06497478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320
Last updated 2025-09-08
Summary
Atherosclerosis is a systemic, multifocal disease that represents the leading cause of death in Western countries. The risk factors contributing to its distribution, extent and progression in different organs (i.e., the heart, brain or limbs) and different segments (large and small vessels) are not identical. The present study analyses data the evolutionary aspects of polydistrict atherosclerosis by analysing the possible role of morphological factors, biomolecular and genetic in the progression of atherosclerotic lesions and the development of major and/or minor acute cardiovascular events.
For this purpose, will be recalled to follow-up all 320 patients already enrolled in the previous protocol of Research in the period between 1 March 2014 and 28 February 2015 at the Department of Internal Medicine, Catholic University of Rome.
The subjects will undergo a new clinical evaluation, with particular interest to the onset of major cardiovascular events (myocardial infarction, stroke, death for all causes) and major adverse events to the lower limbs (critical ischemia of the lower limbs requiring revascularization or amputation) in the follow-up period, and a ultrasonographic examination of carotid arteries and arteries of lower limb districts at the Service of Angiology, Catholic University of Rome.
The study employed a new semiquantitative ultrasonographic score (ultrasonographic lower limb atherosclerosis (ULLA) score), that enables a complete evaluation of the entire lower limb atherosclerotic burden and has already been shown to be associated with major cardiovascular risk factors.
Therefore, the aims of this study are:
* to assess the association between functional, morphological, biomolecular and genetic factors of atherosclerotic disease and the risk of major cardiovascular events (MACE) and major adverse events to the lower limbs (MALE);
* to analyse the morphological progression of atherosclerotic disease in its different localizations and the possible determining factors in such progression with a 10-year follow-up ultrasound study.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Ultrasonographic examination
Ultrasonographic examination will be performed using a high-resolution (Epiq Elite Philips Medical Systems, Monza, Italia) and a linear 12-9 MHz transducer. The patients will be placed in a supine position. Starting with the probe at the base of the neck, the common carotid artery will be explored on the transverse plane and then on the sagittal one, continuing in a cranial sense up to the carotid bifurcation. The medium-intimal thickness will be measured, defined as distance from the first hyperechoic line to the second hyperechoic line. The femoropopliteal and run-off segments will be continuously scanned from the subinguinal region to the paramalleolar region with axial and sagittal scans. All segments will be examined for the presence of vessel wall calcifications and/or atherosclerotic plaques. In addition, flow velocity measurements will be obtained using spectral Doppler imaging and color Doppler imaging.
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
luca Santoro · Fondazione Policlinico Universitario A. Gemelli, IRCCS
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-01
- Primary Completion
- 2024-12-30
- Completion
- 2025-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Ezetimibe and Simvastatin in Dyslipidemia of Diabetes
NCT00157482 ·Status: COMPLETED ·Phase: PHASE2
-
T-Mem GEne in Atherosclerosis
NCT06230406 ·Status: RECRUITING
-
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
NCT02124928 ·Status: UNKNOWN
-
Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
NCT01718288 ·Status: COMPLETED ·Phase: PHASE4
-
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
NCT00751608 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
NCT03872401 ·Status: COMPLETED ·Phase: PHASE3
-
Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.
NCT03921905 ·Status: COMPLETED
-
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
NCT01059682 ·Status: TERMINATED ·Phase: PHASE3
-
Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
NCT04277702 ·Status: UNKNOWN ·Phase: PHASE3
-
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
NCT01813422 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients
NCT00734032 ·Status: COMPLETED ·Phase: PHASE2
-
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
NCT02114697 ·Status: TERMINATED ·Phase: PHASE4
-
Molecular Mechanisms and Carotid Atherosclerosis
NCT03962686 ·Status: COMPLETED
-
Carotid Atherosclerotic Plaque Study
NCT00214006 ·Status: COMPLETED
-
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
NCT03304821 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
NCT00185042 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
NCT00185146 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Evolocumab on Vascular Function
NCT03626831 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.
NCT00720577 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Role of Mitophagy in Myeloid Cells During Coronary Atherosclerosis.
NCT05708547 ·Status: COMPLETED
-
Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes
NCT01419418 ·Status: COMPLETED
-
Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)
NCT01007279 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
NCT04338165 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
NCT06204237 ·Status: RECRUITING ·Phase: EARLY_PHASE1